AC Immune SA (ACIU) stock
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.13−0.01 (-0.47%)
Close on Nov 13, 2026Market cap $216.71MP/E –Yield –
AC Immune cash
Cash and short-term investments held at the end of each period.
AC Immune's cash was CHF 27.76M at Jun 30, 2026. For fiscal 2025 it was CHF 26.80M, down 26.1% from the year before. Over ten years it grew -10.0% a year on average. The highest annual figure on record is CHF 193.59M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 26.80M | -26.1% |
| FY2024 | Dec 31, 2024 | CHF 36.28M | -53.8% |
| FY2023 | Dec 31, 2023 | CHF 78.49M | +148.5% |
| FY2022 | Dec 31, 2022 | CHF 31.59M | -61.6% |
| FY2021 | Dec 31, 2021 | CHF 82.22M | -48.9% |
| FY2020 | Dec 31, 2020 | CHF 160.89M | -16.9% |
| FY2019 | Dec 31, 2019 | CHF 193.59M | +23.7% |
| FY2018 | Dec 31, 2018 | CHF 156.46M | +25.8% |
| FY2017 | Dec 31, 2017 | CHF 124.38M | -18.3% |
| FY2016 | Dec 31, 2016 | CHF 152.21M | +98.9% |
| FY2015 | Dec 31, 2015 | CHF 76.52M | +2214.6% |
| FY2014 | Dec 31, 2014 | CHF 3.31M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | CHF 27.76M | -46.2% |
| Q4 FY2025 | Dec 31, 2025 | CHF 26.80M | -65.9% |
| Q2 FY2025 | Jun 30, 2025 | CHF 25.72M | -35.7% |
| Q4 FY2024 | Dec 31, 2024 | CHF 36.28M | +14.8% |
| Q2 FY2024 | Jun 30, 2024 | CHF 51.56M | +15.9% |
| Q4 FY2023 | Dec 31, 2023 | CHF 78.49M | +24.3% |
| Q2 FY2023 | Jun 30, 2023 | CHF 40.01M | -51.3% |
| Q4 FY2022 | Dec 31, 2022 | CHF 31.59M | -66.2% |
| Q3 FY2022 | Sep 30, 2022 | CHF 44.50M | -72.3% |
| Q2 FY2022 | Jun 30, 2022 | CHF 63.15M | -67.4% |
| Q4 FY2021 | Dec 31, 2021 | CHF 82.22M | -47.5% |
| Q3 FY2021 | Sep 30, 2021 | CHF 93.58M | -24.8% |
| Q4 FY2020 | Dec 31, 2020 | CHF 160.89M | +5.7% |
| Q4 FY2019 | Dec 31, 2019 | CHF 193.59M | +153.0% |
| Q4 FY2018 | Dec 31, 2018 | CHF 156.46M | +4632.7% |
| Q4 FY2017 | Dec 31, 2017 | CHF 124.38M | – |
| Q4 FY2016 | Dec 31, 2016 | CHF 152.21M | – |
| Q4 FY2015 | Dec 31, 2015 | CHF 76.52M | – |
| Q4 FY2014 | Dec 31, 2014 | CHF 3.31M | – |
See a number that looks wrong?